Background: Uterine myomas are the most prevalent benign pelvic tumours among women, with an estimated prevalence of 60% during a woman's lifetime. Objective: This study was interested in determining health findings for female patients who have uterine myomas. Patients and methods: A data study was conducted on women patients with uterine myomas, which included 70 patients who were examined in outpatient units of private clinics or public hospitals in Iraq, which includes all data collected from gynecological diagnostic data, where patient data and the number of visits were collected during the 7-month follow-up. Which included demographic and diagnostic data, surgical data, and risk factors associated with myoma. This study was conducted during a period ranging from March 6, 2022, to October 18, 2023. Results: The study found that women in the age range of 40 to 45 years constituted the largest proportion of cases, with 35 cases. The age group of childbearing age was found to be 62.86%, while the perimenopausal age group accounted for 34.29% and the postmenopausal age group for 2%. The most prevalent symptoms were heavy menstrual bleeding (56 cases), pelvic pain (39 cases), and dysmenorrhoea (30 cases). The types of myomas included submucosal (16 cases), intramural (23 cases), subserosal (21 cases), and other (5 cases). The most common localisations of the myomas were anterior (25 cases). A total of 21 cases of fundus and 14 cases of posterior were identified. The surgical procedures included laparotomic myomectomy (13 cases), laparoscopic myomectomy (5 cases), hysteroscopic myomectomy (5 cases), hysterectomy (22 cases), and other surgical options (3 cases). The median blood loss was 178 mL. The mean ± standard deviation for the number of women experiencing bleeding was 12 ± 10.72. Eight women were admitted to the intensive care unit (ICU), and the mean length of stay in the hospital was 3.20 ± 0.46 days. The most common complications in women with uterine myomas were infection (6 cases), bleeding (2 cases), adhesions (2 cases), and death (4 cases). Conclusion: The study found common symptoms in women with uterine myoma, include heavy menstrual bleeding, pelvic pain, and dysmenorrhea, leading to poor quality of life. In Iraq, surgical intervention is the primary treatment, emphasizing the importance of both non-surgical and surgical therapies in improving symptoms and quality of life